5 unknown, 2 recruiting, 1 completed. 8 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Unknown 5, Recruiting 2, Completed 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow ITP: new trials by email Literature Review of ITP trials Research Report on ITP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP) Efgartigimod IV, Placebo IV - Immune Thrombocytopenia (ITP), ITP - Immune Thrombocytopenia | Phase 2 / Phase 3 | Recruiting | argenx | 24 | 2025-10-20 | 2026-10-16 |
| A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) Budoprutug - Immune Thrombocytopenia (ITP), ITP | Phase 1 / Phase 2 | Recruiting | Climb Bio, Inc. | 24 | 2025-06-30 | 2026-03-27 |
| Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia Baricitinib - ITP, Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 35 | 2022-07-13 | 2022-09-28 |
| Anti-BCMA CAR T-Cell Therapy for R/R ITP autologous anti-BCMA chimeric antigen receptor T cells - ITP | Phase 2 | Unknown | The First Affiliated Hospital of Soochow University | 5 | 2022-01-01 | 2022-04-07 |
| The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Iguratimod, Danazol - ITP, Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 120 | 2021-09-01 | 2022-05-02 |
| The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia Dexamethasone, Tacrolimus - ITP, Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 120 | 2021-03-01 | 2021-02-10 |
| The DART Study- Daratumumab Treatment in ITP Daratumumab Injection - ITP | Phase 2 | Unknown | Ostfold Hospital Trust | 21 | 2021-01-21 | 2024-04-09 |
| Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone High dose Dexamethasone pulses, Prednisone - ITP, Croticosteroid Therapy | Phase 2 / Phase 3 | Completed | Isfahan University of Medical Sciences | 36 | 2016-10-01 | 2017-09-18 |
Purpura, Thrombocytopenic, Idiopathic (5)
Autoimmune Diseases (5) · Blood Coagulation Disorders (5) · Blood Platelet Disorders (5) · Cytopenia (5) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Hemorrhage (5) · Hemorrhagic Disorders (5) · Immune System Diseases (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Purpura (5) · Purpura, Thrombocytopenic (5) · Signs and Symptoms (5) · Skin Manifestations (5)
Danazol (1) · Dexamethasone (1) · Prednisone (1) · Tacrolimus (1) · baricitinib (1) · daratumumab (1) · iguratimod (1)
Peking University People's Hospital (3) · Climb Bio, Inc. (1) · Isfahan University of Medical Sciences (1) · Ostfold Hospital Trust (1) · The First Affiliated Hospital of Soochow University (1) · argenx (1)
China (4) · France (2) · Serbia (2) · Spain (2) · Bulgaria (1) · Denmark (1) · Germany (1) · Greece (1) · Iran (1) · Italy (1) · Japan (1) · Lithuania (1) · Norway (1) · Poland (1) · Romania (1)
Waleed Ghanima, PhD (1) · Xiao-Hui Zhang, MD (1) · Xiaohui Zhang, MD (1)
2025 (1)